2018-2023 Global Bladder Cancer Therapeutics Market Report (Status and Outlook)

September 2018 | 119 pages | ID: 26E6A961AD6EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Bladder Cancer Therapeutics market for 2018-2023.

The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost layer called urothelium or transitional epithelium, composed of epithelium or transitional cells.
The availability of targeted therapy will be one of the major factors driving the growth prospects for the market until the end of 2021. The advancements in drug targeting techniques have enabled doctors to administer drugs directly into the bladder having tumors. This in turn, will help in avoiding side effects of these drugs on healthy cells. With a better understanding of tumor immunology scientists can also now develop new drugs targeted at cancer cells. TECENTRIQ and OPDIVO are the PD-L1 inhibitors recently approved by the US FDA for the treatment of urothelial carcinoma. One of the effective procedures for the diagnosis of bladder cancer, cystoscopy, involves the use of a long thin tube called cystoscope. This helps the urologist to extract a small piece of the abnormal tissue and send it to the pathologists for examination. With the emergence of effective diagnostic tools such as flexible cystoscope, urologists will prefer cystoscopy since it can be easily performed in the outpatient department. This emergence of effective diagnostic tools will be one of the major trends that will gain traction in the bladder cancer therapeutics market during the next four years.
Over the next five years, LPI(LP Information) projects that Bladder Cancer Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Bladder Cancer Therapeutics market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Transitional Cell Bladder Cancer
• Invasive Bladder Cancer
• Squamous Cell Bladder Cancer
• Others

Segmentation by application:

• Hospitals 
• Clinics 
• Other

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Bristol-Myers Squibb
• Eli Lilly
• F. Hoffman-La Roche
• Pfizer
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Bladder Cancer Therapeutics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Bladder Cancer Therapeutics market by identifying its various subsegments.
• Focuses on the key global Bladder Cancer Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Bladder Cancer Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Bladder Cancer Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bladder Cancer Therapeutics Market Size 2013-2023
  2.1.2 Bladder Cancer Therapeutics Market Size CAGR by Region
2.2 Bladder Cancer Therapeutics Segment by Type
  2.2.1 Transitional Cell Bladder Cancer
  2.2.2 Invasive Bladder Cancer
  2.2.3 Superficial Bladder Cancer
  2.2.4 Squamous Cell Bladder Cancer
  2.2.5 Others
2.3 Bladder Cancer Therapeutics Market Size by Type
  2.3.1 Global Bladder Cancer Therapeutics Market Size Market Share by Type (2013-2018)
  2.3.2 Global Bladder Cancer Therapeutics Market Size Growth Rate by Type (2013-2018)
2.4 Bladder Cancer Therapeutics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Other
2.5 Bladder Cancer Therapeutics Market Size by Application
  2.5.1 Global Bladder Cancer Therapeutics Market Size Market Share by Application (2013-2018)
  2.5.2 Global Bladder Cancer Therapeutics Market Size Growth Rate by Application (2013-2018)

3 GLOBAL BLADDER CANCER THERAPEUTICS BY PLAYERS

3.1 Global Bladder Cancer Therapeutics Market Size Market Share by Players
  3.1.1 Global Bladder Cancer Therapeutics Market Size by Players (2016-2018)
  3.1.2 Global Bladder Cancer Therapeutics Market Size Market Share by Players (2016-2018)
3.2 Global Bladder Cancer Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BLADDER CANCER THERAPEUTICS BY REGIONS

4.1 Bladder Cancer Therapeutics Market Size by Regions
4.2 Americas Bladder Cancer Therapeutics Market Size Growth
4.3 APAC Bladder Cancer Therapeutics Market Size Growth
4.4 Europe Bladder Cancer Therapeutics Market Size Growth
4.5 Middle East & Africa Bladder Cancer Therapeutics Market Size Growth

5 AMERICAS

5.1 Americas Bladder Cancer Therapeutics Market Size by Countries
5.2 Americas Bladder Cancer Therapeutics Market Size by Type
5.3 Americas Bladder Cancer Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Bladder Cancer Therapeutics Market Size by Countries
6.2 APAC Bladder Cancer Therapeutics Market Size by Type
6.3 APAC Bladder Cancer Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Bladder Cancer Therapeutics by Countries
7.2 Europe Bladder Cancer Therapeutics Market Size by Type
7.3 Europe Bladder Cancer Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bladder Cancer Therapeutics by Countries
8.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type
8.3 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL BLADDER CANCER THERAPEUTICS MARKET FORECAST

10.1 Global Bladder Cancer Therapeutics Market Size Forecast (2018-2023)
10.2 Global Bladder Cancer Therapeutics Forecast by Regions
  10.2.1 Global Bladder Cancer Therapeutics Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Bladder Cancer Therapeutics Forecast by Type
10.8 Global Bladder Cancer Therapeutics Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Bristol-Myers Squibb
  11.1.1 Company Details
  11.1.2 Bladder Cancer Therapeutics Product Offered
  11.1.3 Bristol-Myers Squibb Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Bristol-Myers Squibb News
11.2 Eli Lilly
  11.2.1 Company Details
  11.2.2 Bladder Cancer Therapeutics Product Offered
  11.2.3 Eli Lilly Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Eli Lilly News
11.3 F. Hoffman-La Roche
  11.3.1 Company Details
  11.3.2 Bladder Cancer Therapeutics Product Offered
  11.3.3 F. Hoffman-La Roche Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 F. Hoffman-La Roche News
11.4 Pfizer
  11.4.1 Company Details
  11.4.2 Bladder Cancer Therapeutics Product Offered
  11.4.3 Pfizer Bladder Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Pfizer News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Bladder Cancer Therapeutics
Figure Bladder Cancer Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Bladder Cancer Therapeutics Market Size Growth Rate 2013-2023 ($ Millions)
Table Bladder Cancer Therapeutics Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Transitional Cell Bladder Cancer
Table Major Players of Invasive Bladder Cancer
Table Major Players of Superficial Bladder Cancer
Table Major Players of Squamous Cell Bladder Cancer
Table Major Players of Others
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global Bladder Cancer Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global Transitional Cell Bladder Cancer Market Size Growth Rate
Figure Global Invasive Bladder Cancer Market Size Growth Rate
Figure Global Superficial Bladder Cancer Market Size Growth Rate
Figure Global Squamous Cell Bladder Cancer Market Size Growth Rate
Figure Global Others Market Size Growth Rate
Figure Bladder Cancer Therapeutics Consumed in Hospitals
Figure Global Bladder Cancer Therapeutics Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Bladder Cancer Therapeutics Consumed in Clinics
Figure Global Bladder Cancer Therapeutics Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Bladder Cancer Therapeutics Consumed in Other
Figure Global Bladder Cancer Therapeutics Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Bladder Cancer Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Bladder Cancer Therapeutics Market Size in Hospitals Growth Rate
Figure Global Bladder Cancer Therapeutics Market Size in Clinics Growth Rate
Figure Global Bladder Cancer Therapeutics Market Size in Other Growth Rate
Table Global Bladder Cancer Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Bladder Cancer Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Bladder Cancer Therapeutics Revenue Market Share by Players in 2017
Table Global Bladder Cancer Therapeutics Key Players Head office and Products Offered
Table Bladder Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Bladder Cancer Therapeutics Market Size by Regions 2013-2018 ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size Market Share by Regions 2013-2018
Figure Global Bladder Cancer Therapeutics Market Size Market Share by Regions 2013-2018
Figure Americas Bladder Cancer Therapeutics Market Size 2013-2018 ($ Millions)
Figure APAC Bladder Cancer Therapeutics Market Size 2013-2018 ($ Millions)
Figure Europe Bladder Cancer Therapeutics Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Bladder Cancer Therapeutics Market Size 2013-2018 ($ Millions)
Table Americas Bladder Cancer Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Americas Bladder Cancer Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Americas Bladder Cancer Therapeutics Market Size Market Share by Countries in 2017
Table Americas Bladder Cancer Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Americas Bladder Cancer Therapeutics Market Size Market Share by Type (2013-2018)
Figure Americas Bladder Cancer Therapeutics Market Size Market Share by Type in 2017
Table Americas Bladder Cancer Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Americas Bladder Cancer Therapeutics Market Size Market Share by Application (2013-2018)
Figure Americas Bladder Cancer Therapeutics Market Size Market Share by Application in 2017
Figure United States Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Canada Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table APAC Bladder Cancer Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table APAC Bladder Cancer Therapeutics Market Size Market Share by Countries (2013-2018)
Figure APAC Bladder Cancer Therapeutics Market Size Market Share by Countries in 2017
Table APAC Bladder Cancer Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table APAC Bladder Cancer Therapeutics Market Size Market Share by Type (2013-2018)
Figure APAC Bladder Cancer Therapeutics Market Size Market Share by Type in 2017
Table APAC Bladder Cancer Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table APAC Bladder Cancer Therapeutics Market Size Market Share by Application (2013-2018)
Figure APAC Bladder Cancer Therapeutics Market Size Market Share by Application in 2017
Figure China Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Japan Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Korea Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure India Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Australia Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Europe Bladder Cancer Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Europe Bladder Cancer Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Europe Bladder Cancer Therapeutics Market Size Market Share by Countries in 2017
Table Europe Bladder Cancer Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Europe Bladder Cancer Therapeutics Market Size Market Share by Type (2013-2018)
Figure Europe Bladder Cancer Therapeutics Market Size Market Share by Type in 2017
Table Europe Bladder Cancer Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Europe Bladder Cancer Therapeutics Market Size Market Share by Application (2013-2018)
Figure Europe Bladder Cancer Therapeutics Market Size Market Share by Application in 2017
Figure Germany Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure France Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure UK Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Italy Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Russia Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Spain Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Bladder Cancer Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Bladder Cancer Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Bladder Cancer Therapeutics Market Size Market Share by Countries in 2017
Table Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Bladder Cancer Therapeutics Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Bladder Cancer Therapeutics Market Size Market Share by Type in 2017
Table Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Bladder Cancer Therapeutics Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Bladder Cancer Therapeutics Market Size Market Share by Application in 2017
Figure Egypt Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Israel Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Bladder Cancer Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Global Bladder Cancer Therapeutics arket Size Forecast (2018-2023) ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size Market Share Forecast by Regions
Figure Americas Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure APAC Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Europe Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure United States Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Canada Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Mexico Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Brazil Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure China Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Japan Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Korea Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure India Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Australia Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Germany Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure France Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure UK Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Italy Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Russia Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Spain Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Egypt Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure South Africa Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Israel Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure Turkey Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Figure GCC Countries Bladder Cancer Therapeutics Market Size 2018-2023 ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size Market Share Forecast by Type (2018-2023)
Table Global Bladder Cancer Therapeutics Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Bladder Cancer Therapeutics Market Size Market Share Forecast by Application (2018-2023)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Bladder Cancer Therapeutics Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Bladder Cancer Therapeutics Market Share (2016-2018)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Bladder Cancer Therapeutics Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Bladder Cancer Therapeutics Market Share (2016-2018)
Table F. Hoffman-La Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. Hoffman-La Roche Bladder Cancer Therapeutics Revenue and Gross Margin (2016-2018)
Figure F. Hoffman-La Roche Bladder Cancer Therapeutics Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Bladder Cancer Therapeutics Revenue and Gross Margin (2016-2018)
Figure Pfizer Bladder Cancer Therapeutics Market Share (2016-2018)